Aug. 3 at 7:05 AM
$HUMA If we go off what I have seen recently, "68 VACs in progress" here is how you can look at that:
Why a VAC review usually indicates intent to purchase:
1. Resource-intensive: VAC reviews involve physician champions, finance, risk management, and materials management. Hospitals don’t usually waste that effort unless there’s real clinical interest.
2. Triggered by clinician request: Most VACs are initiated because a physician (trauma surgeon, vascular surgeon, etc.) requests use of the product—usually after a case where existing options failed or were suboptimal.
3. Symvess targets high-acuity, life-saving use: Its indication (urgent vascular reconstruction when no suitable conduit is available) means hospitals wouldn't even bother reviewing it unless their trauma/vascular teams anticipated rare but real use cases.
